Cellular Dynamics International, Inc.
Registered Principal Details
Business Or Interest:
Manufacturer of human iPSCs and tissue cells.
Lobbying Interests:
Issues of concern to biomedical and pharmaceutical industries involving the regulation of human cell biology.
CEO Name:
Robert Palay
President
Manufacturer of human iPSCs and tissue cells.
Lobbying Interests:
Issues of concern to biomedical and pharmaceutical industries involving the regulation of human cell biology.
CEO Name:
Robert Palay
President
Contact
TP
Thomas Palay
525 Science Drive
Madison, WI 53711
(608) 310-5100
(608) 310-5125
tpalay@cellulardynamics.com
http://www.cellulardynamics.com
525 Science Drive
Madison, WI 53711
(608) 310-5100
(608) 310-5125
tpalay@cellulardynamics.com
http://www.cellulardynamics.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 181
Relating to: venture capital investment program. (FE)
Bill Text and History
2013 Wisconsin Act 41
5/8/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: venture capital investment program. (FE)
Bill Text and History
2013 Wisconsin Act 41
For
Notification Date5/8/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 169
Relating to: venture capital investment program. (FE)
Bill Text and History
5/13/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: venture capital investment program. (FE)
Bill Text and History
For
Notification Date5/13/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
issues of concern to biomedical and pharmaceutical industries involving the regulation of human cell biology.
Development, drafting or introduction of a proposal relating to
issues of concern to biomedical and pharmaceutical industries involving the regulation of human cell biology.
issues of concern to biomedical and pharmaceutical industries involving the regulation of human cell biology.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/7/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/7/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2013 January - June $25,740.00 |
2013 July - December $24,000.00 |
2014 January - June $24,000.00 |
2014 July - December $0.00 |
Total $73,740.00 |
| Total Hours Communicating | 2013 January - June 17.75 |
2013 July - December 4.00 |
2014 January - June 7.00 |
2014 July - December 0.00 |
Total 28.75 |
| Total Hours Other | 2013 January - June 29.00 |
2013 July - December 14.00 |
2014 January - June 4.25 |
2014 July - December 0.00 |
Total 47.25 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: venture capital investment program. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June 17% |
2013 July - December 50% |
2014 January - June |
2014 July - December |
Total 22% |
Relating to: venture capital investment program. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June 26% |
2013 July - December 50% |
2014 January - June |
2014 July - December |
Total 28% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
issues of concern to biomedical and pharmaceutical industries involving the regulation of human cell biology.
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June 57% |
2013 July - December |
2014 January - June 100% |
2014 July - December 100% |
Total 50% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.